Impaired Beta Cell Glucose Sensitivity Rather Than Inadequate Compensation for Insulin Resistance is the Dominant Defect in Glucose Intolerance

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2010 Mar 13

PMID 20225397

Citations 43

Authors

A Mari

A Tura

A Natali

M Laville

M Laakso

R Gabriel

H Beck-Nielsen

E Ferrannini

Affiliations

Soon will be listed here.

Abstract

Aims/hypothesis: It is commonly thought that hyperglycaemia results from insufficient compensation of insulin secretion for insulin resistance. To verify this hypothesis, we assessed beta cell function and insulin sensitivity (IS) in a large cohort of volunteers with normal glucose tolerance (NGT) or impaired glucose regulation (IGR), i.e. impaired glucose tolerance or impaired fasting glucose.

Methods: In men and women with NGT (n=1,123) or IGR(n=156) (age 44 +/- 8 years, BMI 25+/-4 kg/m2, mean +/- SD)we measured: (1) IS by clamp; (2) insulin secretion rates(ISR) and beta cell glucose sensitivity (=slope of the insulin secretion/plasma glucose dose-response) by C-peptide deconvolution and OGTT modelling; and (3) acute insulin response to intravenous glucose.

Results: After controlling for centre, sex, age and BMI, fasting and total ISR were inversely related to IS in both groups,whereas beta cell glucose sensitivity was not. Acute insulin response was reciprocally related to IS in both groups, but the relationships were incompatible with inadequate compensation and significance was lost after controlling for fasting ISR. InIGR vs NGT, IS was impaired (92 [75] vs 133 [86] micromol min(-1)[kg fat-free mass](-1) [nmol/l](-1), median [interquartile range],p<0.0001) as was beta cell glucose sensitivity (69 [46] vs 119[83] pmol min(-1) m(-2) [nmol/l](-1), p<0.0001), whereas fasting and total ISR were increased (35% and 25%, respectively, p<0.0001). In fully adjusted models, beta cell glucose sensitivity was the strongest determinant of OGTT glucose levels.

Conclusions/interpretation: Insulin resistance normally upregulates the secretory tone, with no evidence of defective compensation in IGR. In contrast, beta cell glucose sensitivity is independent of insulin resistance, but a key determinant of glucose tolerance. This suggests that hyperglycaemia results from an intrinsic beta cell defect rather than from inadequate compensation for insulin resistance.

Citing Articles

In-silico modelling of insulin secretion and pancreatic beta-cell function for clinical applications: is it worth the effort?.

Tura A, Gobl C, El-Tanani M, Rizzo M Front Clin Diabetes Healthc. 2024; 5:1452400.

PMID: 39559404 PMC: 11570995. DOI: 10.3389/fcdhc.2024.1452400.

Quantifying beta cell function in the preclinical stages of type 1 diabetes.

Galderisi A, Carr A, Martino M, Taylor P, Senior P, Dayan C Diabetologia. 2023; 66(12):2189-2199.

PMID: 37712956 PMC: 10627950. DOI: 10.1007/s00125-023-06011-5.

Effects of PCSK9 inhibition on glucose metabolism and β-cell function in humans: a pilot study.

Moffa S, Mezza T, Ferraro P, Giuseppe G, Cefalo C, Cinti F Front Endocrinol (Lausanne). 2023; 14:1124116.

PMID: 37324254 PMC: 10266211. DOI: 10.3389/fendo.2023.1124116.

TyGIS: improved triglyceride-glucose index for the assessment of insulin sensitivity during pregnancy.

Salvatori B, Linder T, Eppel D, Morettini M, Burattini L, Gobl C Cardiovasc Diabetol. 2022; 21(1):215.

PMID: 36258194 PMC: 9580191. DOI: 10.1186/s12933-022-01649-8.

Exercise mode influences post-exercise glucose sensitivity and insulin clearance in young, healthy males and females in a sex-dependent manner: A randomized control trial.

Beaudry K, Surdi J, Mari A, Devries M Physiol Rep. 2022; 10(13):e15354.

PMID: 35785485 PMC: 9251832. DOI: 10.14814/phy2.15354.

References

Walker M, Mari A, Jayapaul M, Bennett S, Ferrannini E . Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects. Diabetologia. 2005; 48(12):2470-6. DOI: 10.1007/s00125-005-0004-7. View

Ahren B, Pacini G . Islet adaptation to insulin resistance: mechanisms and implications for intervention. Diabetes Obes Metab. 2005; 7(1):2-8. DOI: 10.1111/j.1463-1326.2004.00361.x. View

Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo R . beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab. 2004; 90(1):493-500. DOI: 10.1210/jc.2004-1133. View

Hills S, Balkau B, Coppack S, Dekker J, Mari A, Natali A . The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia. 2004; 47(3):566-570. DOI: 10.1007/s00125-004-1335-5. View

Kahn S . The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia. 2003; 46(1):3-19. DOI: 10.1007/s00125-002-1009-0. View

Jones C, Pei D, Staris P, Polonsky K, Chen Y, Reaven G . Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals. J Clin Endocrinol Metab. 1997; 82(6):1834-8. DOI: 10.1210/jcem.82.6.3979. View

Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E . Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab. 2002; 283(6):E1159-66. DOI: 10.1152/ajpendo.00093.2002. View

Weyer C, Bogardus C, Mott D, Pratley R . The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest. 1999; 104(6):787-94. PMC: 408438. DOI: 10.1172/JCI7231. View

Chang A, Smith M, Galecki A, Bloem C, Halter J . Impaired beta-cell function in human aging: response to nicotinic acid-induced insulin resistance. J Clin Endocrinol Metab. 2006; 91(9):3303-9. DOI: 10.1210/jc.2006-0913. View

10.

Stumvoll M, Tataranni P, Stefan N, Vozarova B, Bogardus C . Glucose allostasis. Diabetes. 2003; 52(4):903-9. DOI: 10.2337/diabetes.52.4.903. View

11.

Mari A, Tura A, Pacini G, Kautzky-Willer A, Ferrannini E . Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes. Diabet Med. 2008; 25(6):671-7. DOI: 10.1111/j.1464-5491.2008.02441.x. View

12.

. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997; 20(7):1183-97. DOI: 10.2337/diacare.20.7.1183. View

13.

Kim S, Catalano K, Hsu I, Chiu J, Richey J, Bergman R . Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia. Am J Physiol Endocrinol Metab. 2007; 292(6):E1590-8. DOI: 10.1152/ajpendo.00669.2006. View

14.

Utzschneider K, Prigeon R, Carr D, Hull R, Tong J, Shofer J . Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses. Diabetes Care. 2006; 29(2):356-62. DOI: 10.2337/diacare.29.02.06.dc05-1963. View

15.

Van Citters G, Kabir M, Kim S, Mittelman S, Dea M, Brubaker P . Elevated glucagon-like peptide-1-(7-36)-amide, but not glucose, associated with hyperinsulinemic compensation for fat feeding. J Clin Endocrinol Metab. 2002; 87(11):5191-8. DOI: 10.1210/jc.2002-020002. View

16.

Van Cauter E, Mestrez F, Sturis J, Polonsky K . Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 1992; 41(3):368-77. DOI: 10.2337/diab.41.3.368. View

17.

DeFronzo R, Tobin J, Andres R . Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979; 237(3):E214-23. DOI: 10.1152/ajpendo.1979.237.3.E214. View

18.

Gautier J, Wilson C, Weyer C, Mott D, Knowler W, Cavaghan M . Low acute insulin secretory responses in adult offspring of people with early onset type 2 diabetes. Diabetes. 2001; 50(8):1828-33. DOI: 10.2337/diabetes.50.8.1828. View

19.

Cerasi E . Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible?. Diabetologia. 1995; 38(8):992-7. DOI: 10.1007/BF00400591. View

20.

Bergman R, Ader M, Huecking K, Van Citters G . Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes. 2002; 51 Suppl 1:S212-20. DOI: 10.2337/diabetes.51.2007.s212. View